Literature DB >> 19955550

Evaluation of percutaneous endoscopic feeding tube placement in obese patients.

Travis F Wiggins1, Donald A Garrow, Mark H DeLegge.   

Abstract

BACKGROUND: Percutaneous endoscopic feeding tube placement is generally safe and effective for establishing enteral access. In certain subpopulations, such as obese patients, substantial data are limited. This study evaluates the success rate and potential for late complications with placement of feeding tubes in obese patients.
METHODS: The Medical University of South Carolina endoscopy database was queried for adult patients with a body mass index >or=30 kg/m(2) who had undergone percutaneous endoscopic gastrostomy, percutaneous endoscopic gastrojejunostomy, and direct percutaneous jejunostomy placement procedures between the years 2000 and 2006.
RESULTS: Sixty-seven subjects met the inclusion criteria. Percutaneous endoscopic feeding tube placement was successful in 60 of 67 individuals (89.6%) with an average procedure time of 15.5 minutes (range, 5-70 minutes). Postplacement complications occurred in 26 of 59 subjects (44.1%) and included peristomal pain (8.5%), cellulitis (8.5%), inadvertent removal (6.8%), peritubular leak (6.8%), nausea (3.4%), and hemoperitoneum (3.4%). In multivariable logistic regression analysis, weight >250 pounds (>113 kg) predicted a significantly increased likelihood of complications (adjusted odds ratio = 3.86; 95% confidence interval, 1.02-14.57). Other covariates did not significantly affect the complication rate.
CONCLUSIONS: Percutaneous enteral access device placement in obese patients is generally safe, and a body mass index >or=30 kg/m(2) alone should not be a procedural contraindication. Adherence to safe enteral access placement techniques and close periprocedure follow-up should occur in obese patients, especially those weighing >250 pounds (>113 kg). More research is needed to fully evaluate the efficacy of enteral access in this population.

Entities:  

Mesh:

Year:  2009        PMID: 19955550     DOI: 10.1177/0884533609349250

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  4 in total

1.  Aspiration therapy leads to weight loss in obese subjects: a pilot study.

Authors:  Shelby Sullivan; Richard Stein; Sreenivasa Jonnalagadda; Daniel Mullady; Steven Edmundowicz
Journal:  Gastroenterology       Date:  2013-09-06       Impact factor: 22.682

2.  Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.

Authors:  Christopher C Thompson; Barham K Abu Dayyeh; Robert Kushner; Shelby Sullivan; Alan B Schorr; Anastassia Amaro; Caroline M Apovian; Terrence Fullum; Amir Zarrinpar; Michael D Jensen; Adam C Stein; Steven Edmundowicz; Michel Kahaleh; Marvin Ryou; J Matthew Bohning; Gregory Ginsberg; Christopher Huang; Daniel D Tran; Joseph P Glaser; John A Martin; David L Jaffe; Francis A Farraye; Samuel B Ho; Nitin Kumar; Donna Harakal; Meredith Young; Catherine E Thomas; Alpana P Shukla; Michele B Ryan; Miki Haas; Heidi Goldsmith; Jennifer McCrea; Louis J Aronne
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

3.  Complications Associated with Enteral Nutrition: CAFANE Study.

Authors:  Carmina Wanden-Berghe; Maria-Carmen Patino-Alonso; Purificación Galindo-Villardón; Javier Sanz-Valero
Journal:  Nutrients       Date:  2019-09-01       Impact factor: 5.717

4.  Aspiration Therapy As a Tool to Treat Obesity: 1- to 4-Year Results in a 201-Patient Multi-Center Post-Market European Registry Study.

Authors:  Max Nyström; Evzen Machytka; Erik Norén; Pier Alberto Testoni; Ignace Janssen; Jesus Turró Homedes; Jorge Carlos Espinos Perez; Roman Turro Arau
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.